familial amyloid polyneuropathy

Alnylam’s rare disease drug shines in trial, paving way for a brand-new class of medicines
Stat
Wed, 09/20/17 - 09:27 am
Alnylam
rare disease
Patisiran
familial amyloid polyneuropathy
RNAi
GSK Hands Nerve Drug Back to Ionis as RNA Battle Heats Up
Xconomy
Fri, 08/11/17 - 11:37 am
GSK
Ionis
familial amyloid polyneuropathy
RNA
inotersen
Alnylam Drug Scores Against Rare Nerve Disease
Investors.com
Mon, 10/13/14 - 04:02 pm
Alnylam
Patisiran
familial amyloid polyneuropathy
Isis Pharmaceuticals receives $1M milestone payment from GlaxoSmithKline
The Fly on the Wall
Tue, 06/24/14 - 10:22 am
GSK
Isis Pharmaceuticals
ISIS-TTRRx
familial amyloid polyneuropathy
Pfizer says FDA wants a new study of Vyndaqel
Yahoo/AP
Mon, 06/18/12 - 09:21 pm
FDA
Pfizer
Vyndaqel
familial amyloid polyneuropathy
The Meaningless Drug Approval That Could Cost the Industry Billions
Motley Fool
Mon, 05/28/12 - 11:16 am
drug approvals
Pfizer
tafamidis
familial amyloid polyneuropathy
FDA Panel Sends Mixed Message About Pfizer Drug
Pharmalot
Fri, 05/25/12 - 11:19 am
FDA
advisory panel
Pfizer
tafamidis
familial amyloid polyneuropathy
FDA staff shoots down Pfizer rare disease drug
Yahoo/Reuters
Tue, 05/22/12 - 11:19 am
FDA
Pfizer
Vyndaqel
familial amyloid polyneuropathy